Beacon Investment Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$650K Sell
1,847
-1
-0.1% -$356 0.25% 91
2025
Q4
$605K Hold
1,848
0.24% 90
2025
Q3
$522K Buy
1,848
+1
+0.1% +$290 0.21% 98
2025
Q2
$512K Hold
1,847
0.22% 99
2025
Q1
$576K Sell
1,847
-14
-0.8% -$4.13K 0.27% 92
2024
Q4
$485K Hold
1,861
0.23% 104
2024
Q3
$600K Hold
1,861
0.28% 88
2024
Q2
$581K Sell
1,861
-7,499
-80% -$2.2M 0.3% 87
2024
Q1
$2.66M Buy
9,360
+18
+0.2% +$5.27K 1.52% 16
2023
Q4
$2.69M Buy
9,342
+116
+1% +$31.6K 1.72% 13
2023
Q3
$2.48M Buy
9,226
+34
+0.4% +$8.48K 1.75% 12
2023
Q2
$2.04M Buy
9,192
+8,327
+963% +$1.93M 1.39% 16
2023
Q1
$209K Hold
865
0.15% 120
2022
Q4
$227K Buy
+865
New +$232K 0.19% 117

Other funds holding AMGN

Beacon Investment Advisors's AMGN Position: Q1 2026 in Review

Beacon Investment Advisors reduced its Amgen (AMGN) stake by 0.05% in Q1 2026, selling an estimated $356 and leaving 1,847 shares worth $650K. The position accounts for 0.25% of the portfolio, ranked #91.

Beacon Investment Advisors first reported a position in AMGN in Q4 2022 and has held it in 14 quarters since. The position peaked at $2.69M in Q4 2023. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Beacon Investment Advisors held 1,847 shares of Amgen worth $650K as of Q1 2026.
  • Beacon Investment Advisors sold 1 Amgen share in Q1 2026, an estimated $356.
  • Amgen made up 0.25% of Beacon Investment Advisors's portfolio in Q1 2026, its #91 holding.
  • Beacon Investment Advisors first reported a position in Amgen in Q4 2022 and has held it in 14 quarters since.
  • Beacon Investment Advisors's Amgen position peaked at $2.69M in Q4 2023.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Beacon Investment Advisors's 13F filing for Q1 2026, filed 14 May 2026.